Faeth Therapeutics, Inc. (FTH)
Nasdaq: FTH · Pharmaceutical Preparations · Rockville, MD · filing with the SEC since 2020
Who runs Faeth Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Parikh Anand Kiran
President and CEO. First filing Feb 2026, latest Nov 3, 2026, 1 filing in all.
Officers reporting now
4
of 11 people with a filing in the last fifteen months
Directors reporting now
7
26 people on the record since 2021
Officerssales are open-market, Nov 3, 2025 to Nov 3, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Parikh Anand Kiran | President and CEO | Feb 2026 | Nov 3, 2026 | none |
| Craver Josiah | PAO | Sep 2024 | Jul 23, 2026 | none |
| Stephenson Brian C | Chief Financial Officer | Jun 2026 | Jul 1, 2026 | none |
| Gerry Christopher | President & PEO | Nov 2025 | Jun 12, 2026 | none |
Directorssales are open-market, Nov 3, 2025 to Nov 3, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Schayowitz Adam | director | Oct 2026 | Oct 27, 2026 | none |
| Vousden Karen H | director | Sep 2026 | Sep 15, 2026 | none |
| Hahn Stephen M. | director | Jun 2026 | Jun 16, 2026 | none |
| Ramasastry Saira | director | Jun 2026 | Jun 16, 2026 | none |
| Donenberg Phillip B. | director | Feb 2026 | Jun 12, 2026 | none |
| Holmen Bob | director | Feb 2021 | Jun 12, 2026 | none |
| Peyer James | director | Feb 2021 | Jun 1, 2026 | 10 · $800,000 |
Owners of more than 10% of a classsales are open-market, Nov 3, 2025 to Nov 3, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Khosla Ventures Associates Vi, LLC | 10% owner | Jul 2026 | Jul 28, 2026 | none |
| Khosla Ventures Seed Associates D, LLC | 10% owner | Jul 2026 | Jul 28, 2026 | none |
| Khosla Ventures Seed D, L.P. | 10% owner | Jul 2026 | Jul 28, 2026 | none |
| Khosla Ventures Vi, L.P. | 10% owner | Jul 2026 | Jul 28, 2026 | none |
| Khosla Vinod | 10% owner | Jul 2026 | Jul 28, 2026 | none |
| Vk Services, LLC | 10% owner | Jul 2026 | Jul 28, 2026 | none |
| Cambrian Biopharma Inc | 10% owner | Feb 2021 | Jun 1, 2026 | 10 · $800,000 |
| Englander Israel A | 10% owner | Mar 2026 | May 15, 2026 | none |
| Ics Opportunities II LLC | 10% owner | Mar 2026 | May 15, 2026 | 18 · $600,000 |
| Millennium Group Management LLC | 10% owner | Mar 2026 | May 15, 2026 | none |
| Millennium Management LLC | 10% owner | Mar 2026 | May 15, 2026 | 7 · $100,000 |
Earlier names on the record24, newest filing first
Humer Kristian · director · last filing May 2025Ricks Thomas G · director · last filing May 2025Ringo William R · director · last filing May 2025Celebi John · officer · last filing Feb 2025Van Der Horst Edward · officer · last filing Feb 2025Krebs Stephanie · officer · last filing Feb 2025English Jessie · director · last filing Jun 2024Vojta Deneen · director · last filing Jun 2024Gaiero David G · officer · last filing May 2024Colgan Erin · officer · last filing Feb 2024Gallagher Patrick Stephen · officer · last filing Sep 2023Broder Samuel · director · last filing Jul 2023Angermayer Christian · 10% owner · last filing Jun 2023Apeiron Investment Group Ltd. · 10% owner · last filing Jun 2023Presight Co-Invest Management, L.L.C. · 10% owner · last filing Jun 2023Presight Sensei Co-Invest Fund, L.P. · other · last filing Jun 2023Pierce Robert Hamilton · officer · last filing Sep 2022H&s Investments I LP · 10% owner · last filing Feb 2021H&s Ventures LLC · 10% owner · last filing Feb 2021Samueli Henry · 10% owner · last filing Feb 2021Samueli Susan · 10% owner · last filing Feb 2021Schulman Michael · 10% owner · last filing Feb 2021Fjaellskog Marie-Louise · officer · last filing Feb 2021Hoey Anupama · officer · last filing Feb 2021
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.